Bianca Altvater

11PUBLICATIONS
44CO-AUTHORS
Molecular targetsChemical engineering designHaematological tumoursSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 29, 2024
Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid Liposarcoma.

Lorena Heinst, Kwang Seok Lee, Ruth Berthold

|Apr 09, 2024
Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers.

Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann

|Jun 30, 2023
CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process.

Bianca Altvater, Sareetha Kailayangiri, Christian Spurny

|Oct 14, 2022
Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma.

Sebastian Fuest, Christoph Post, Sebastian T Balbach

|May 14, 2022
The Cellular Tumor Immune Microenvironment of Childhood Solid Cancers: Informing More Effective Immunotherapies.

Malcolm Holterhus, Bianca Altvater, Sareetha Kailayangiri

|Jul 02, 2021
HLA-G and HLA-E Immune Checkpoints Are Widely Expressed in Ewing Sarcoma but Have Limited Functional Impact on the Effector Functions of Antigen-Specific CAR T Cells.

Bianca Altvater, Sareetha Kailayangiri, Lina F Pérez Lanuza

Pageof 2

Frequent Collaborators

9 joint publications

Claudia Rossig

5 joint publications

Sareetha Kailayangiri

4 joint publications

Marcel Trautmann

4 joint publications

Ilka Isfort